Charmacy Pharmaceutical Co., Ltd.

HKEX:2289.HK

8.35 (HKD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income 24.99226.35369.83320.639-2.80825.9619.68330.873-2.15142.305-0.20745.641.84142.91919.69636.7631.12525.2349.99626.4499.111
Depreciation & Amortization 12.61311.99715.31515.36316.87315.16213.23311.3212.82711.1129.9548.4877.3516.7715.9645.5144.5714.4114.7354.992.985
Deferred Income Tax 0000000000000177.0390000000
Stock Based Compensation 00000000000000.9890000000
Change In Working Capital -187.183-104.34-9.351-290.859180.004-159.063-273.24145.388-176.347132.508-30.03836.255-60.333-178.028-78.087-59.15-234.2680-28.719-105.889-21.363
Accounts Receivables -133.53935.36518.488-240.95598.923-153.734-205.44947.42-127.577126.76-41.70289.049-80.157-77.606-76.886-28.502-160.8660-68.161-77.3140
Change In Inventory -53.644-139.706-27.839-49.90481.081-5.329-67.791-2.032-48.775.74711.664-52.79319.824-100.422-1.201-30.648-73.402039.442-28.5752.717
Change In Accounts Payables 000000000000000000-53.30124.080
Other Working Capital 00000000000000000000-24.08
Other Non Cash Items 281.819-162.79-0.306223.416-103.818.137601.083-307.262180.264-196.498114.48-135.4259.0586.48-36.7544.503287.863104.734-1.16174.7735.56
Operating Cash Flow 132.242-228.7875.491-31.44190.259-109.802350.758-219.68114.593-10.57494.189-45.0387.909-40.869-89.181-12.3759.291134.379-15.1490.323-3.707
Investing Activities:
Investments In Property Plant And Equipment -10.671-30.177-6.128-2.46-3.354-21.685-24.348-27.634-47.262-26.641-49.853-47.873-111.17-14.456-7.673-11.902-1.656-0.497-1.275-3.172-1.112
Acquisitions Net 000000-1.856-10000000000000
Purchases Of Investments 000000000000000000000
Sales Maturities Of Investments 000000000000000000000
Other Investing Activites 0.12580.06180.0540.2980.6310.0070.0250.0340.0510.1090.0520.1060.0162.248-2.0432.081-98.379-67.33821.77523.5751.112
Investing Cash Flow -10.54649.88473.925-2.163-2.724-21.678-26.18-28.6-47.211-26.533-49.802-47.768-111.154-12.208-9.716-9.821-100.035-67.83520.520.4038.872
Financing Activities:
Debt Repayment 00000-2.2160-118.7630-520-4.700000000-65.765
Common Stock Issued 000000000000000000000
Common Stock Repurchased 000000000000000000000
Dividends Paid -63.524-11.977-13.753-14.687-27.52-24.974-29.564-26.948-42.436-19.138-15.467-32.893-27.453-23.632-37.1020-16-30000
Other Financing Activities -38.155214.918-134.801-27.9749.04175.637-242.391177.46480.319-16.617-20.56593.385108.98355.719119.163-2.469187.671-34.1385.467-26.00965.765
Financing Cash Flow -101.679202.941-148.555-42.65721.52152.88-271.955269.27837.88216.244-36.03265.19281.53132.08882.061-2.469171.671-64.1385.467-26.009-65.64
Other Information:
Effect Of Forex Changes On Cash -0.0070.0130.0170.017-0.2410.241-0.0070.0080.0070.0020.015-0.115-0.08-1.6885.926155.629-155.62922.29673.30861.85861.858
Net Change In Cash 024.0570.879-76.244108.816-78.3652.61621.0055.271-20.8618.37-27.729-21.795-22.677-10.91130.969-24.70224.70227.4297.2881.384
Cash At End Of Period 92.91992.91973.73172.852144.22735.411113.77161.15540.14934.87855.73947.36875.09796.892120.059130.969024.70238.90711.4785.574